Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
121 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
 		Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
122 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2021
123 Increase in polymorphonuclear myeloid‑derived suppressor cells and regulatory T‑cells in children with B‑cell acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Amira Mahmoud Mohammed Osman 2021
124 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
125 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2021
126 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Department of Pathology Saly Salah Abdelhakeem 2021
127 Association of robust radiomic features from staging18F-FDG PET/CT in lung cancer with EGFR over expression and overall survival Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
128 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Murad Aly Jabir Ahmed 2021
129 HLA-B* 15 predicts survival in Egyptian patients with COVID-19 Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2021
130 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2021